Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-03-13 17:06:42

expired found date

-

created at

2024-06-27 03:06:05

updated at

2026-02-21 13:24:46

Domain name statistics

length

12

crc

51300

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

173561409

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

567481

mp size raw text

2255

mp inner links count

2

mp inner links status

20 (imported)

Open Graph

title

Home | FibroGen anemia, pancreatic cancer

description

FibroGen's research and development teams seek to identify and develop medicines for the treatment of chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis (IPF), and l

image

site name

FibroGen

author

updated

2026-01-02 03:49:24

raw text

Home | FibroGen anemia, pancreatic cancer top of page Medical Information FibroGen China Newsroom Contact About Us Our Company Our Strategy FibroGen China Executive Team Board of Directors Scientific Advisory Board Our Partners ESG Medical Information Contact Us Focus Area Our Expertise Pancreatic Cancer Prostate Cancer Duchenne Muscular Dystrophy Anemia Publications Pipeline R&D Pipeline Pamrevlumab Roxadustat FG-3246 Clinical Trials Our Priorities Pamrevlumab Trials FG-3246 Trials Careers Our Culture Career Opportunities Investors and Media Investor Overview Stock Information News Releases Events and Presentations Corporate Governance SEC Filings Financial Information Shareholder Services Investor FAQs More Use tab to navigate through the menu items. Accelerating the Development of Novel Therapies at the Frontiers of Cancer Biology LEARN MORE Pipeline We are developing products with...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medicine [en] (226)

index version

2025123101

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

1745

text words

273

text unique words

132

text lines

107

text sentences

7

text paragraphs

0

text words per sentence

39

text matched phrases

7

text matched dictionaries

2

RSS

rss path

rss status

1 (priority 1 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)

sitemap review version

2

sitemap urls count

32

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-03-13 05:40:37

sitemap process date

2025-04-05 08:07:13

sitemap first import date

-

sitemap last import date

2026-02-21 13:24:46